PapersFlow Research Brief
Influenza Virus Research Studies
Research Guide
What is Influenza Virus Research Studies?
Influenza Virus Research Studies is a cluster of 138,012 papers focusing on the research and epidemiology of influenza viruses, including H1N1, pandemic potential, vaccine efficacy, viral pathogenesis, and antibody development.
This field covers molecular structure to global burden and transmission patterns of influenza viruses. Janeway and Medzhitov (2002) showed innate immune recognition relies on germline-encoded receptors detecting microbial products, with 8276 citations. Akira and Takeda (2004) demonstrated Toll-like receptor signalling in immune responses, cited 8138 times.
Topic Hierarchy
Research Sub-Topics
Influenza Vaccine Efficacy
This sub-topic evaluates clinical trial outcomes, immunogenicity, and real-world effectiveness of seasonal and pandemic influenza vaccines across populations. Researchers study strain matching, booster strategies, and adjuvanted formulations.
Influenza Viral Evolution
This sub-topic examines antigenic drift, shift, and phylodynamics of influenza A and B viruses using genomic surveillance data. Studies model evolutionary rates and predict future variants for vaccine updates.
Influenza Pathogenesis Mechanisms
This sub-topic investigates host-virus interactions, including receptor binding, replication kinetics, and cytokine storms in respiratory epithelia. Researchers explore animal models and human challenge studies for therapeutic targets.
Influenza Epidemiology and Surveillance
This sub-topic analyzes global transmission patterns, burden of disease, and nowcasting methods using syndromic and genomic data. Studies assess interventions like school closures and travel restrictions.
Influenza Antigenic Determinants
This sub-topic maps hemagglutinin and neuraminidase epitopes, computational prediction of B-cell sites, and escape mutants. Researchers develop tools for epitope mapping and universal vaccine design.
Why It Matters
Influenza research informs vaccine recommendations and antiviral strategies, as Harper et al. (2001) updated ACIP guidelines on strains for 1997-98 season vaccines, cited 5043 times. Thompson et al. (2003) quantified mortality, finding influenza deaths increased substantially in the last 2 decades among elderly, underscoring need for better vaccines, with 3665 citations. Ginsberg et al. (2008) developed search engine query data for detecting epidemics, enabling early surveillance, cited 4330 times. Recent developments include NIH SBIR award to Cocrystal Pharma (2025) for influenza inhibitors and Osivax $19.5 million BARDA support (2025) for broad-spectrum vaccine.
Reading Guide
Where to Start
'Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)' by Harper et al. (2001) first, as it provides practical ACIP guidelines on vaccines and antivirals for the 1997-98 season, offering an accessible entry to epidemiology and control.
Key Papers Explained
Janeway and Medzhitov (2002) 'Innate Immune Recognition' establishes germline receptors for pathogen detection, foundational for Akira and Takeda (2004) 'Toll-like receptor signalling' that details downstream pathways. Webster et al. (1992) 'Evolution and ecology of influenza A viruses' traces avian origins, informing epidemiology in Harper et al. (2001) ACIP recommendations and Ginsberg et al. (2008) real-time detection methods. Shu and McCauley (2017) 'GISAID' builds on these by enabling genomic data sharing for surveillance.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Phase 3 trials of modified mRNA influenza vaccines show promising efficacy (Pfizer C4781004, 2025). Quadrivalent vaccines induce humoral and cellular responses in phase 3 trials (2025). NIH funds transmission consortia (2025) and networks, while Osivax advances universal vaccines with BARDA support (2025). H3N2 subclade K dominates 2025/26 season with reduced vaccine reactivity.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Innate Immune Recognition | 2002 | Annual Review of Immun... | 8.3K | ✕ |
| 2 | Toll-like receptor signalling | 2004 | Nature reviews. Immuno... | 8.1K | ✕ |
| 3 | Prevention and Control of Influenza: Recommendations of the Ad... | 2001 | PsycEXTRA Dataset | 5.0K | ✕ |
| 4 | Detecting influenza epidemics using search engine query data | 2008 | Nature | 4.3K | ✓ |
| 5 | Evolution and ecology of influenza A viruses | 1992 | Microbiological Reviews | 4.2K | ✓ |
| 6 | Prediction of protein antigenic determinants from amino acid s... | 1981 | Proceedings of the Nat... | 3.7K | ✓ |
| 7 | Mortality Associated With Influenza and Respiratory Syncytial ... | 2003 | JAMA | 3.7K | ✓ |
| 8 | A crucial role of angiotensin converting enzyme 2 (ACE2) in SA... | 2005 | Nature Medicine | 3.6K | ✓ |
| 9 | GISAID: Global initiative on sharing all influenza data – from... | 2017 | Eurosurveillance | 3.4K | ✓ |
| 10 | Virus interference. I. The interferon | 1957 | Proceedings of the Roy... | 3.4K | ✕ |
In the News
Cocrystal Pharma Receives NIH SBIR Award to Advance ...
# Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program October 27, 2025 Download as PDF
Influenza Transmission Research Consortium (P01 Clinical Trial Optional)
The purpose of this notice of funding opportunity (NOFO) is to support basic research to understand the fundamental mechanisms underlying human-to-human transmission of seasonal influenza virus. Th...
NIH funds new influenza research network
# NIH funds new influenza research network
UI researcher loses grant funding amid NIH shakeup
Christopher Brooke, researcher and professor in LAS, was awarded a grant from the National Institutes of Health two years ago to research how seasonal influenza viruses evolve. In November, he was ...
Osivax receives $19.5 million BARDA support for universal ...
Health and Human Services (HHS), to develop a broad-spectrum influenza A candidate vaccine for pandemic and seasonal flu preparedness.
Code & Tools
Zoe provides both broad and highly specialized implementations for
FluPipe provides a fully automated, flexible and reproducible workflow for reconstructing genome sequences from Illumina NGS data. The pipeline is ...
This is a Nextflow pipeline for running the FluViewer analysis tool and other custom modules to obtain consensus sequences, HA and NA subtypes, cla...
## Repository files navigation # flu-ngs Influenza virus next generation sequence analysis pipeline. Highlights:
## Software Packages for Influenza Research _R Packages_
Recent Preprints
Influenza virus - Latest research and news
* Metabolic regulation of host defence against viral infection through sensing oxaloacetate
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine
quadrivalent modRNA influenza vaccine candidate has shown promising immunogenicity and an acceptable safety profile in a phase 1–2 investigation. 14 We conducted a phase 3 efficacy trial — A Study ...
Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial
Annual vaccination is an effective strategy for preventing severe disease caused by seasonal influenza. Quadrivalent influenza vaccines (QIVs) protect against two strains of influenza A and two str...
A vaccine central in A(H5) influenza antigenic space confers broad immunity
### Subjects * Influenza virus * Viral evolution ## Abstract
Early influenza virus characterisation and vaccine ...
Influenza A(H3N2) subclade K (J.2.4.1) has dominated the 2025/26 season start in England. Post-infection ferret antisera raised against northern hemisphere 2025/26 vaccine strains showed reduced re...
Latest Developments
Recent research indicates that the 2025-2026 influenza season is driven by a highly mutated variant, specifically a subclade K, which has contributed to a surge in cases and is being referred to by some as the "super flu" (nature.com, published January 14, 2026; Stanford Medicine, January 12, 2026; AAMC, January 13, 2026). Additionally, studies have highlighted the antigenic evolution of influenza A(H5) viruses and efforts to design broader-spectrum vaccines to combat such evolving strains (nature.com, published November 12, 2025; nature.com](https://www.nature.com/articles/s41586-025-09626-3), published October 15, 2025).
Sources
Frequently Asked Questions
What is the role of innate immune recognition in influenza?
Innate immune recognition uses germline-encoded receptors to detect conserved microbial products from pathogens like influenza. Janeway and Medzhitov (2002) established this as a universal host defense mechanism. The paper 'Innate Immune Recognition' has 8276 citations.
How do Toll-like receptors contribute to influenza defence?
Toll-like receptors mediate signalling in innate immunity against influenza viruses. Akira and Takeda (2004) detailed this in 'Toll-like receptor signalling', with 8138 citations. These pathways activate host responses to viral infection.
What are ACIP recommendations for influenza control?
ACIP provides updates on influenza vaccines and antivirals. Harper et al. (2001) in 'Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)' covered 1997-98 strains, cited 5043 times. Recommendations guide seasonal prevention.
How can search data detect influenza epidemics?
Search engine queries predict influenza outbreaks. Ginsberg et al. (2008) showed this in 'Detecting influenza epidemics using search engine query data', with 4330 citations. The method tracks real-time transmission patterns.
What is the ecological source of influenza viruses?
Aquatic birds serve as the primordial source of influenza A viruses. Webster et al. (1992) analyzed this in 'Evolution and ecology of influenza A viruses', cited 4173 times. Phylogenetic studies support perpetuation in avian species.
What is GISAID's role in influenza research?
GISAID enables global sharing of influenza data. Shu and McCauley (2017) described it in 'GISAID: Global initiative on sharing all influenza data – from vision to reality', with 3434 citations. It facilitates genomic surveillance.
Open Research Questions
- ? How do seasonal influenza viruses evolve to evade vaccines, as explored in recent NIH-funded networks?
- ? What metabolic pathways, such as oxaloacetate sensing, regulate host defence against influenza?
- ? Can modified mRNA vaccines achieve superior efficacy over traditional quadrivalent influenza vaccines?
- ? Which vaccine formulations confer broad immunity against evolving H5 influenza antigenic space?
- ? What mechanisms underlie human-to-human transmission of seasonal influenza, per new consortia?
Recent Trends
NIH funded new influenza research networks and transmission consortium (2025), with Cocrystal Pharma receiving SBIR award for inhibitors (2025).
2025Osivax secured $19.5 million BARDA support for universal influenza vaccine.
2025Preprints report phase 3 mRNA vaccine efficacy (Pfizer C4781004, 2025), broad H5 immunity, and H3N2 subclade K dominance in 2025/26 with reduced vaccine effectiveness.
Tools like FluPipe and fluviewer-nf advance NGS genome analysis.
Research Influenza Virus Research Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Influenza Virus Research Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers